Krystal Biotech, Inc. (KRYS)
NASDAQ: KRYS · Real-Time Price · USD
337.02
-6.32 (-1.84%)
Aug 20, 2026, 4:00 PM EDT - Market closed
Krystal Biotech Employees
Krystal Biotech had 295 employees as of December 31, 2025. The number of employees increased by 20 or 7.27% compared to the previous year.
Employees
295
Change (1Y)
20
Growth (1Y)
7.27%
Revenue / Employee
$1,493,166
Profits / Employee
$818,522
Market Cap
9.98B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 295 | 20 | 7.27% | 295 | 0 |
| Dec 31, 2024 | 275 | 46 | 20.09% | 275 | 0 |
| Dec 31, 2023 | 229 | 19 | 9.05% | 229 | 0 |
| Dec 31, 2022 | 210 | 91 | 76.47% | 210 | 0 |
| Dec 31, 2021 | 119 | 44 | 58.67% | 119 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Ionis Pharmaceuticals | 1,480 |
| Axsome Therapeutics | 1,346 |
| Cytokinetics | 673 |
| Vaxcyte | 507 |
| Kymera Therapeutics | 273 |
| Summit Therapeutics | 265 |
| Apogee Therapeutics | 261 |
| Praxis Precision Medicines | 168 |
KRYS News
- 4 days ago - Krystal Biotech initiated with an Outperform at RBC Capital - TheFly
- 16 days ago - Krystal Biotech price target lowered to $392 from $396 at BofA - TheFly
- 17 days ago - Krystal Biotech price target raised to $386 from $378 at Citi - TheFly
- 17 days ago - Krystal Biotech Earnings Call Transcript: Q2 2026 - Transcripts
- 17 days ago - Krystal Biotech Earnings release: Q2 2026 - Filings
- 17 days ago - Krystal Biotech Quarterly report: Q2 2026 - Filings
- 17 days ago - Krystal Biotech Slides: Q2 2026 - Filings
- 17 days ago - Krystal Biotech reports Q2 EPS $1.79, consensus $1.91 - TheFly